An index tracking gaming stocks listed in Hong Kong also saw a 5.7 percent surge. The rise in gaming stocks also came after Macau released its updated budget for 2022, expecting gross gaming revenue to be 130 billion patacas (HK$126.54 billion). Among vaccine-related stocks, Wuxi Biologics Cayman (2269), which makes ingredients for AstraZeneca's vaccine, was the biggest loser as it slumped 8.6 percent. CanSino Biologics (6185), a Chinese Covid vaccine makers, plunged 17 percent and Sino Biopharmaceutical (1177) declined 1.6 percent. If successful, Pfizer's pill "may create uncertainties for earnings outlook and valuations of Chinese vaccine makers," said Daniel So of CMB International Securities.

Source: The Standard November 08, 2021 22:49 UTC